Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 307 - Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 307 - Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (1,726)
01/2011
01/13/2011US20110008261 Method to produce hyperpolarised amino acids and aminosulphonic acids
01/12/2011CN201701929U Sulfamic acid continuous production synthesis reaction kettle
01/04/2011US7863476 Multifunctional anionic surfactants
12/2010
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/21/2010US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine
11/2010
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/17/2010EP2249828A1 Preparation of sulfamide derivatives
11/10/2010EP1773762B1 Methods and compounds for detection of medical disorders
11/02/2010US7825278 Central nervous system disorders; gamma aminobutyric acid (GABA) receptor complex modulators
11/02/2010US7824918 mono- and bis-substituted 8-hydroxypyrene-1,3,6-trisulfonic acid dyes (HPTA) containing pyrene rings; hydrogels; glucose sensors
10/2010
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/26/2010US7820846 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents
10/19/2010US7816560 N-nonyl-1,5,6-trideoxy-1,5-imino-D-galactitol; N-(7-oxa-nonyl)-1,5,6-trideoxy-1,5-imino-D-galactito; viricide; for treating hepatitis
10/14/2010US20100261924 Asymmetric catalyst and process for preparing optically active alcohols using the same
10/13/2010CN101391759B Sulfamic acid production process
10/12/2010US7811473 Branched surfactant having fluoroalkyl group and hydrocarbon group
10/07/2010WO2010115000A2 Methods and intermediates for preparing pharmaceutical agents
10/07/2010WO2010113835A1 Method for producing imidic acid compound
10/07/2010US20100256231 Novel derivatives of 3,3-diphenylpropylamines
10/07/2010CA2754698A1 Methods and intermediates for preparing pharmaceutical agents
09/2010
09/23/2010US20100240657 Chemical compounds
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/09/2010US20100228054 Method for Producing Sulfonamides
09/02/2010US20100222317 Azetidine Derivatives as GlyT1 Inhibitors
09/01/2010CN101821233A Method for producing sulfonic acid diamides
08/2010
08/26/2010US20100216859 Curcumin analog compositions and related methods
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/11/2010CN101801921A Novel sulfamate compounds for medical use
08/10/2010US7772430 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
08/10/2010CA2391832C Oral dosage forms
07/2010
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100190725 Amino acid derivatives
07/21/2010EP2207766A1 Novel sulfamate compounds for medical use
07/20/2010US7759518 Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
07/15/2010US20100179224 Acyclic Sulfamide Derivatives
07/15/2010US20100176345 Branched surfactant having fluoroalkyl group and hydrocarbon group
07/08/2010US20100174113 Aromatic sulphonylimides, preparation thereof and use thereof as electrolyte
06/2010
06/24/2010US20100160304 Aromatic sulfone compound as aldosterone receptor modulator
06/23/2010CN101754947A Process for preparation of sulfamide derivatives
06/22/2010US7741361 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/17/2010US20100152297 Composition for regulating cellular senescence comprising n-[2-(cyclohexy-loxyl)-4-nitrophenyl]-methanesulfonamide
06/09/2010CN101730678A Amino acid derivatives
05/2010
05/26/2010CN101712640A methods and compositions for treating amyloid-related diseases
05/20/2010US20100125090 Modulators of ATP-Binding Cassette Transporters
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
04/2010
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/22/2010US20100099769 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
04/21/2010EP2176217A1 Amino acid derivatives
04/20/2010CA2418744C Novel aminocyclohexane derivatives
04/15/2010US20100094052 Process for preparing acylsulfamoylbenzamides
04/15/2010US20100093707 Acid amide derivatives, process for their production and pesticides containing them
04/13/2010USRE41226 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
04/08/2010WO2010037271A1 A group of amino substituted benzoyl derivatives and their preparation and their use
04/08/2010CA2738256A1 A group of amino substituted benzoyl derivatives and their preparation and their use
03/2010
03/23/2010US7683096 Acid amide derivatives, process for producing these, and pest control agent containing these
03/16/2010US7678941 Polyoxyalkylene ammonium salts and their use as antistatic agents
02/2010
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048712 Acyclic Sulfamide Derivatives
02/24/2010EP2155659A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
02/23/2010CA2329930C Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
01/2010
01/27/2010EP1303503B1 Aniline derivatives
01/21/2010US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
12/2009
12/30/2009CN101613310A Method of preparing amine stereoisomers
12/23/2009EP1506169B1 Method for the production of sulphonic acid diamides
12/22/2009US7635711 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
12/17/2009US20090312570 antiviral hepatitis C virus NS5B polymerase inhibitors; intermediates such as 2-methoxycarbonylmethylcarbonylamino-5-methylsulfonaminobenzenesulfonamide
12/15/2009CA2525854C Acylsulfamide inhibitors of factor viia
12/09/2009EP2129654A1 Novel antagonists of the glucagon receptor
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/08/2009US7629298 Sandstone having a modified wettability and a method for modifying the surface energy of sandstone
11/2009
11/24/2009CA2385882C Tyrosine derivatives
11/11/2009CN100558701C N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/10/2009US7615187 Carbonylsulfamide and carbonylsulfoxamide derivatives; producing organic sterilizing agents when combined with percarbonate or perborate compound in aqueous medium; disinfecting medical equipment, air conditioner interiors, foodstuffs, plants, animal enclosures
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
10/2009
10/29/2009WO2009132241A2 Proton conducting materials
10/29/2009WO2009129938A1 Substituted phenoxybenzamides
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/07/2009CN101553461A 4-substituted phenoxyphenylacetic acid derivatives
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598269 3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-1-propanesulfonic acid; reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity
09/2009
09/30/2009EP2104497A2 Urea and sulfamide derivatives as tafia inhibitors
09/17/2009US20090234014 Naphthalene-Disulfonamides Useful for the Treatment of Inflammation
09/08/2009US7585997 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
09/03/2009US20090221710 Acyclic Sulfamide Derivatives
08/2009
08/19/2009CN100528841C Sulfonamide compound
08/19/2009CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
08/12/2009CN101506154A Compounds for treating proliferative disorders
08/11/2009US7572463 Oral dosage forms
08/06/2009US20090197201 Fluorosurfactants
07/2009
07/29/2009EP1363876B1 Glucocorticoid receptor modulators
07/21/2009USRE40861 4-Trimethylammonium-3-(nonylcarbamoyl)-aminobutyrate; hypoglycemic agents; antidiabetic agents; antiischemic agents; congestive heart failure; obesity
07/16/2009WO2009089235A1 Preparation of sulfamide derivatives
07/16/2009US20090182141 Process for the preparation of sulfamide derivatives
07/08/2009CN100509771C Method for the production of sulphamic acid halogenides
06/2009
06/23/2009US7550629 4-chloro-N-[(1S)-3,3,3-trifluoro-1-(hydroxymethyl)-2-(trifluoromethyl)propyl]benzenesulfonamide; 4-cyano-N-(3,3,3-trifluoro-1-hydroxymethyl-2-trifluoromethyl-propyl)-benzenesulfonamide; Alzheimer's Disease, amyloid angiopathy, systemic amyloidosis, mild cognitive impairment and Down's syndrome
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 18